Announcements Trials
Browse Landscape

Phase

Phase 2 18Phase 1 11Phase 3 7Phase 1/2 7Phase NA 4Phase EARLY_PHASE1 2Phase 2/3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Osteosarcoma 1

Interventions

Cisplatin 30Magnetic Resonance Spectroscopy 23Carboplatin 23pembrolizumab 21Paclitaxel 20Gemcitabine 19Specimen Handling 16Doxorubicin 15Dexamethasone 15Radiotherapy 14Nivolumab 14Drug Therapy 14Cyclophosphamide 14Bevacizumab 14atezolizumab 13Oxaliplatin 13Vincristine 11Radiation 11Prednisone 11Pemetrexed 11Cytarabine 11venetoclax 10Docetaxel 10Capecitabine 10Trastuzumab 9Rituximab 9Temozolomide 8Platinum 8Ipilimumab 8Fluorouracil 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Phantoms, Imaging × 1 year × Clear all
NCT05691478 2026-06-03

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

National Cancer Institute (NCI)

Phase 2/3 Recruiting
1,122 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡